Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

NCT05162898 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Recurrent Hepatocellular Cancer

Interventions

DRUG: toripalimab
DRUG: Lenvatinib
DEVICE: Radiofrequency ablation

Sponsor

Henan Cancer Hospital